Halozyme Therapeutics, Inc. (HALO)
NASDAQ: HALO · Real-Time Price · USD
60.08
+1.03 (1.74%)
Jul 30, 2025, 4:00 PM - Market closed

Halozyme Therapeutics Employees

Halozyme Therapeutics had 350 employees as of December 31, 2024. The number of employees decreased by 23 or -6.17% compared to the previous year.

Employees
350
Change (1Y)
-23
Growth (1Y)
-6.17%
Revenue / Employee
$3,098,017
Profits / Employee
$1,386,751
Market Cap
7.40B

Employees Chart

Employees History

DateEmployeesChangeGrowth
Dec 31, 2024350-23-6.17%
Dec 31, 2023373-20-5.09%
Dec 31, 2022393248171.03%
Dec 31, 202114596.62%
Dec 31, 202013643.03%
Dec 31, 2019132-149-53.02%
Dec 31, 20182812610.20%
Dec 31, 2017255-4-1.54%
Dec 31, 20162594319.91%
Dec 31, 20152166341.18%
Dec 31, 2014153-17-10.00%
Dec 31, 20131701811.84%
Dec 31, 20121521712.59%
Dec 31, 20111353332.35%
Dec 31, 2010102-38-27.14%
Dec 31, 2009140107.69%
Dec 31, 20081303841.30%
Dec 31, 20079252130.00%
Dec 31, 200640--
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.